Cargando…

Role of Phosphodiesterase-5 Inhibitors in Acute Right Ventricular Failure Due to Pulmonary Embolism

Patient: Male, 56 Final Diagnosis: Right heart failure due to pulmonary embolism Symptoms: Syncope Medication: — Clinical Procedure: — Specialty: Cardiology OBJECTIVE: Unusual clinical course BACKGROUND: Sildenafil is a pulmonary vasodilator and its efficacy has been well established in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Munish, Suero-Abreu, Giselle A., Neupane, Ritesh, Kim, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690213/ https://www.ncbi.nlm.nih.gov/pubmed/31377751 http://dx.doi.org/10.12659/AJCR.915832

Ejemplares similares

A Case of Acute Heart Failure due to Immune Checkpoint Blocker Nivolumab
por: Sharma, Munish, et al.
Publicado: (2019)

Phosphodiesterase‐5 inhibitors for left ventricular assist device implantation complicated by right ventricular failure
por: Papathanasiou, Maria, et al.
Publicado: (2023)

Supportive care of right ventricular failure due to fat embolism syndrome
por: Schwalbach, Kevin T., et al.
Publicado: (2021)

Unusual Presentation Chronic Pulmonary Embolism due to Calcified Right Ventricular Mass
por: Hyun, Yu Kyung, et al.
Publicado: (2011)

Echocardiographic Evaluation of Initial Ambrisentan Plus Phosphodiesterase Type 5 Inhibitor on Right Ventricular Pulmonary Artery Coupling in Severe Pulmonary Arterial Hypertension Patients
por: Lan, Wei-Fang, et al.
Publicado: (2022)

Right Ventricular Variants and Pulmonary Embolism—Association or Coincidence?
por: Ker, James
Publicado: (2010)

Prediction of right ventricular dysfunction in patients with pulmonary embolism
por: Volschan, A, et al.
Publicado: (2005)

Isolated right ventricular noncompaction caused ventricular tachycardia and pulmonary embolism
por: Huo, Qian, et al.
Publicado: (2019)

Proteomic and Metabolomic Analyses of Right Ventricular Failure due to Pulmonary Arterial Hypertension
por: Qin, Xiaohan, et al.
Publicado: (2022)

Targeted therapy with phosphodiesterase 5 inhibitors in patients with pulmonary hypertension due to heart failure and elevated pulmonary vascular resistance: a systematic review
por: Sanchez Palacios, Galo M., et al.
Publicado: (2020)

Isolated right ventricular noncompaction caused recurrent pulmonary embolism
por: Cao, Yan–Jun, et al.
Publicado: (2018)

Isolated Right Ventricular Noncompaction Cardiomyopathy Causing Pulmonary Embolism
por: Seecheran, Rajeev Virender, et al.
Publicado: (2021)

Impella RP: A Promising Intervention in Acute Right Ventricular Failure Caused by Massive Pulmonary Embolism
por: Taha, Ahmed, et al.
Publicado: (2019)

Reversal of severe angioproliferative pulmonary arterial hypertension and right ventricular hypertrophy by combined phosphodiesterase-5 and endothelin receptor inhibition
por: Cavasin, Maria A, et al.
Publicado: (2014)

The use of a durable right ventricular assist device for isolated right ventricular failure due to combined pre- and postcapillary pulmonary hypertension
por: Vullaganti, Sirish, et al.
Publicado: (2019)

Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors
por: Ovchinnikov, Artem, et al.
Publicado: (2022)

Severe pulmonary hypertension and right ventricular failure
por: Kumar, Ajay, et al.
Publicado: (2017)

Pathophysiology of right ventricular failure in acute pulmonary embolism and chronic thromboembolic pulmonary hypertension: a pictorial essay for the interventional radiologist
por: Bryce, Yolanda C., et al.
Publicado: (2019)

Electrical Remodeling in Right Ventricular Failure Due to Pulmonary Hypertension: Unraveling Novel Therapeutic Targets
por: Park, John F., et al.
Publicado: (2023)

Revisiting Atrioventricular Nodal Ablation and Cardiac Pacing of Atrial Fibrillation in a Patient with Dextrocardia
por: Sharma, Munish, et al.
Publicado: (2018)

The electrocardiogram as a predictor of right ventricular dysfunction in patients with pulmonary embolism
por: Volschan, A, et al.
Publicado: (2001)

Right Ventricular Thrombus in Transit: Raising the Stakes in the Management of Pulmonary Embolism
por: Lai, Everett, et al.
Publicado: (2019)

Acute Right Ventricular Failure in the Setting of Acute Pulmonary Embolism or Chronic Pulmonary Hypertension: A Detailed Review of the Pathophysiology, Diagnosis, and Management
por: Matthews, Jennifer Cowger, et al.
Publicado: (2008)

Isolated Right Ventricular Air Embolism()
por: Chaaban, Nourhan, et al.
Publicado: (2022)

Predictors and prognosis of right ventricular function in pulmonary hypertension due to heart failure with reduced ejection fraction
por: Schmeißer, Alexander, et al.
Publicado: (2021)

Saddle pulmonary embolism with normal right ventricular function: a treatment enigma
por: Daher, Iyad N, et al.
Publicado: (2010)

Saddle pulmonary embolism: right ventricular strain an indicator for early surgical approach
por: Namana, Vinod, et al.
Publicado: (2016)

Freely moving right ventricular thrombus in a patient with acute pulmonary embolism
por: Mahajan, Kunal, et al.
Publicado: (2017)

Evaluation of cardiac biomarkers and right ventricular dysfunction in patients with acute pulmonary embolism
por: Dursunoğlu, Neşe, et al.
Publicado: (2016)

McConnell’s Sign Is Not Always Pulmonary Embolism: The Importance of Right Ventricular Ischemia
por: Rafie, Nikita, et al.
Publicado: (2022)

Radiological Cardiothoracic Ratio as a Potential Predictor of Right Ventricular Enlargement in Patients with Suspected Pulmonary Embolism Due to COVID-19
por: Truszkiewicz, Krystian, et al.
Publicado: (2021)

Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors
por: Al-Ameri, H, et al.
Publicado: (2009)

CTPA pulmonary artery distensibility in assessment of severity of acute pulmonary embolism and right ventricular function
por: Wang, Dawei, et al.
Publicado: (2021)

Evolution of Phosphodiesterase-5 Inhibitors
por: Moon, Du Geon
Publicado: (2015)

Revisiting One of the Dreaded Outcomes of the Current Pandemic: Pulmonary Embolism in COVID-19
por: Sharma, Munish, et al.
Publicado: (2020)

Phosphodiesterase-5 Inhibitors Improve Clinical Outcomes, Exercise Capacity and Pulmonary Hemodynamics in Patients With Heart Failure With Reduced Left Ventricular Ejection Fraction: A Meta-Analysis
por: De Vecchis, Renato, et al.
Publicado: (2017)

Study on the clinical efficacy of specific phosphodiesterase inhibitor in patients with pulmonary hypertension due to left heart disease
por: Han, Bing, et al.
Publicado: (2018)

Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: safety, tolerability, and efficacy
por: Buckley, Mitchell S, et al.
Publicado: (2010)

Phosphodiesterase type 5 inhibitors after left ventricular assist device: no free lunch?
por: Grandin, E. Wilson, et al.
Publicado: (2021)

The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases
por: Butrous, Ghazwan
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qf1unet1imhcft68h3ep4pe977